Could a common numbing drug replace opioids after cancer surgery?
NCT ID NCT02894710
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving the numbing drug lidocaine through a vein during and after ear, nose, and throat cancer surgery could lower the need for strong opioid painkillers and reduce long-term pain. 143 adults having major head and neck cancer surgery were randomly assigned to receive either lidocaine or a placebo. Researchers measured how much morphine patients needed in the first two days after surgery and checked for chronic pain 3 to 6 months later.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOLOGIC EAR, NOSE, AND THROAT (ENT) SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Léon Bérard
Lyon, 69008, France
-
Hospices Civils de Lyon / Hôpital de la Croix Rousse
Lyon, 69004, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tailored nutrition boost recovery from head and neck surgery?
- Can less radiation be safer for throat cancer?
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Can a new drug boost the power of chemoradiation against head and neck cancer?
- Exercise after cancer therapy: a new way to gauge prognosis?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?